Fundamentalsinfo compiles publicly available fundamental information on Indian listed companies to help you do your own analysis.

All Reports

Balaji Amines Ltd.

NSE: BALAMINESSmall Cap

Current Price

1,827.85

As of 20 May 2026

Market Cap

₹5.71K Cr

As of 20 May 2026

cyclical recovery year, Rs.871 Cr capex pipeline

Report updated: 2026-05-18

fundamentalsinfo.comLive

Balaji Amines Ltd.

NSE: BALAMINES· Small Cap

India's largest aliphatic amines manufacturer — 2,93,600 TPA capacity expanding to 4,15,100 TPA (+41%), FY22 cyclical peak (Rs.2,314 Cr / Rs.418 Cr PAT) bottomed FY25 (Rs.1,389 Cr / Rs.159 Cr) and FY26 is the recovery year: Q4 FY26 cons EBITDA margin 25% (highest in 8 quarters), FY26 PAT Rs.169 Cr (+6%). Reddy family promoters 54.59%; standalone zero-debt but consolidated debt rose 11x from Rs.11 Cr to Rs.133 Cr in FY26 funding the Rs.750 Cr BSCL expansion + Rs.150-200 Cr standalone capex still pending.

Rs.1,706

Share price

Rs.5,531 Cr

Market cap (Small Cap)

Rs.169 Cr

FY26 net profit

33.1x

Trailing P/E

2.80x

Price to Book

8.75%

ROE (FY26)

Stock Funda Summary

  • Balaji Amines is a 38-year-old chemicals company (founded 1988) and India's largest manufacturer of aliphatic amines (methylamines + ethylamines) and 40+ import-substitute specialty intermediates.
  • Highly cyclical: FY22 windfall peak (Rs.2,314 Cr / Rs.418 Cr PAT / 27% EBITDA margin / 32% ROE) on global supply tightness
  • FY24-FY25 down-cycle (revenue Rs.1,671 → Rs.1,430 Cr, PAT Rs.232 → Rs.159 Cr, ROE collapsed to 8.6%) on China dumping in DMF / EDA + pricing reset.
  • FY26 is the recovery year: Q4 FY26 consolidated revenue Rs.403 Cr (+20% QoQ) at 25% EBITDA margin (highest in 8 quarters, vs 18% Q3 trough), FY26 PAT Rs.169 Cr (+6%).
  • Rs.871 Cr capex pipeline (Rs.750 Cr BSCL + Rs.150-200 Cr standalone for DME, ACN with new tech, NMM, NBPT) set to commission in FY27.
  • Capacity 2,93,600 TPA → 4,15,100 TPA (+41%).
  • MD targets FY28 Rs.3,000 Cr / FY29 Rs.4,000 Cr revenue (+115-180% vs FY26).
  • Risks: FII trimmed 210 bps in 4 quarters; hotel division loss-making (Rs.11 Cr EBIT loss FY26); consol debt jumped 11x to Rs.133 Cr funding the capex; capex-to-revenue ratio deteriorated (Rs.440 Cr spent in 2 years but topline still 38% below FY22 peak).
  • Reddy family promoters 54.59% steady; standalone remains zero-debt.
  • Rated AA-(Stable) by India Ratings.

Educational content only. Not SEBI-registered investment advice. This is public source-based data. Do your own analysis.